phenylbutazone has been researched along with Kidney Failure, Chronic in 7 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients had phenylbutazone-induced systemic vasculitis syndrome." | 7.67 | Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. ( Dobbie, JW; Jones, JM; Leung, AC; McLay, A, 1985) |
| "Two patients had phenylbutazone-induced systemic vasculitis syndrome." | 3.67 | Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. ( Dobbie, JW; Jones, JM; Leung, AC; McLay, A, 1985) |
| " Due to many different pharmacokinetic properties, no perfect rules for dosage in acute or chronic hemodialysis exist." | 1.27 | Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis. ( Forycki, Z; Ibe, K; Martens, F; Thalhofer, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heidelmann, G | 1 |
| Burck, G | 1 |
| Dauterstedt, W | 1 |
| Heinrich, JJ | 1 |
| Ohlmer, R | 1 |
| Held, H | 1 |
| Enderle, C | 1 |
| Kshirsagar, NA | 1 |
| Pahujani, SM | 1 |
| Paul, T | 1 |
| Sheth, UK | 1 |
| van Peer, AP | 1 |
| Belpaire, FM | 1 |
| Bogaert, MG | 1 |
| Forycki, Z | 1 |
| Martens, F | 1 |
| Thalhofer, S | 1 |
| Ibe, K | 1 |
| Leung, AC | 1 |
| McLay, A | 1 |
| Dobbie, JW | 1 |
| Jones, JM | 1 |
| Serre, H | 1 |
| Simon, L | 1 |
| Claustre, J | 1 |
7 other studies available for phenylbutazone and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Indications for and methods of allopurinol-benzbromarone combination therapy in the treatment of hyperuricemic metabolic disorders].
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Drug Interactions; Drug Therapy, Combination; | 1982 |
Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Topics: Adult; Blood Urea Nitrogen; Creatinine; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Me | 1976 |
Phenylbutazone protein binding in normal subjects and hypoproteinemic patients.
Topics: Adult; Female; Humans; Hypoproteinemia; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; | 1979 |
In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
Topics: Animals; Antipyrine; In Vitro Techniques; Kidney Failure, Chronic; Kinetics; Liver; Oxidation-Reduct | 1978 |
Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis.
Topics: Acetaminophen; Acute Kidney Injury; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Benzodia | 1985 |
Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis.
Topics: Acute Kidney Injury; Aged; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Female; Glomerulonep | 1985 |
[Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
Topics: Adult; Aged; Allopurinol; Colchicine; Drug Synergism; Female; Gout; Humans; Kidney Calculi; Kidney F | 1970 |